Meningokokkensepsis ohne Liquorpathologie unter Eculizumabtherapie-Reference-Cited by-同舟云学术

Meningokokkensepsis ohne Liquorpathologie unter Eculizumabtherapie

Published:2019-03-08 Issue:4 Volume:115 Page:340-342
ISSN:2193-6218
Container-title:Medizinische Klinik - Intensivmedizin und Notfallmedizin
language:de
Short-container-title:Med Klin Intensivmed Notfmed

Author:

Jentzsch Madlen,Schwind Sebastian,Vucinic Vladan,Wendt Sebastian,Stingu Catalina-Suzana,Niederwieser Dietger,Weidhase Lorenz

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine,Emergency Nursing,Emergency Medicine,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00063-019-0552-0.pdf

Reference11 articles.

1. Hill A, Kelly RJ, Hillmen P (2013) Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 121:4985–4996

2. Hegenbart U, Niederwieser D, Forman S et al (2003) Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant 9:689–697

3. Schubert J, Roeth A (2014) Update on paroxysmal nocturnal haemoglobinuria: on the long way to understand the principles of the disease. Eur J Haematol 94:464–473

4. Hillmen P, Muus P, Dührsen U et al (2007) Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 110:4123–4128

5. Kaplan SL, Schutze GE, Leake JA et al (2006) Multicenter surveillance of invasive meningococcal infections in children. Pediatr Electron Pages 118:e979–e984

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical hemolytic-uremic syndrome: evolution of treatment and impact of clinical and genetic characteristics on possibility of eculizumab withdrawal;Nephrology (Saint-Petersburg);2022-09-09